KWESST Announces Supplemental Listing of December 9, 2022 Warrants on TSXV
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Ottawa,…
Year: 2023
TFS Financial Corporation Announces Second Fiscal Quarter 2023 Results
Remains Strong, Stable and Well-Capitalized CLEVELAND–(BUSINESS WIRE)–TFS Financial Corporation (NASDAQ: TFSL) (the “Company”), the holding…
Hess Sanctions Uaru Development Offshore Guyana
Uaru development on Stabroek Block receives government approval with production targeted to begin in 2026…
ExxonMobil Guyana Advances Fifth Offshore Guyana Development
Uaru project receives government approvals; production targeted to begin in 2026 Fifth Stabroek block development…
CORRECTING and REPLACING Top Supply Chain-Focused Private Equity Firm, Red Arts Capital, Adds CFO As The Firm Builds On Its Rapid Growth
The Black-founded PE firm continues its commitment to hiring a diverse leadership team CHICAGO–(BUSINESS WIRE)–Please…
Satellogic Reports Full Year 2022 Financial Results and Provides Business Update
Revenue up 42% in 2022 to $6.0 million Primarily from Asset Monitoring with Constellation-as-a-Service Business…
Flux Power Renews $14 Million Credit Facility with First Citizens Bank
VISTA, Calif.–(BUSINESS WIRE)–Flux Power Holdings, Inc. (NASDAQ: FLUX), a developer of advanced lithium-ion energy storage…
iLearningEngines, a leader in AI-Powered Learning Automation, to List on NASDAQ via Merger with Arrowroot Acquisition Corp.
The transaction has a minimum cash condition of $100 million, including funds from the Arrowroot…
NuStar Energy L.P. Declares First Quarter 2023 Common Unit Distribution and Series A, Series B and Series C Preferred Units Distributions
SAN ANTONIO–(BUSINESS WIRE)–NuStar Energy L.P. (NYSE: NS) today announced that its Board of Directors has…
Bridge Net Lease, a Subsidiary of Bridge Investment Group, Acquires Manufacturing Asset in California and Distribution Asset in Illinois
SALT LAKE CITY–(BUSINESS WIRE)–Bridge Net Lease announced that it has acquired an off-market manufacturing asset…
Oncternal Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Tempest to Report Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
Webcast Conference Call Friday, April 28, 2023, at 8:30 a.m. ET BRISBANE, Calif., April 27,…
Taysha Gene Therapies Announces Presentation on New Preclinical Data for TSHA-102 in Rett Syndrome at Upcoming American Society of Gene and Cell Therapy 26th Annual Meeting
DALLAS, April 27, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage…
Mineralys Therapeutics to Participate in the Bank of America Securities 2023 Health Care Conference on Wednesday, May 10, 2023
RADNOR, Pa., April 27, 2023 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage…
Cellectis to Report First Quarter 2023 Financial Results on May 4, 2023
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
Eagle Pharmaceuticals to Host First Quarter 2023 Financial Results on May 9, 2023
WOODCLIFF LAKE, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (“Eagle” or the…
Sutro Biopharma Announces the Departure of President of Research & Chief Scientific Officer
SOUTH SAN FRANCISCO, Calif., April 27, 2023 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or…
GENFIT Announces Publication of Extra-Financial Performance Report 2022
GENFIT Announces Publication of Extra-Financial Performance Report 2022 Lille (France); Cambridge, (Massachusetts, United States); Zurich…
NewMarket Corporation Increases Quarterly Dividend
RICHMOND, Va.–(BUSINESS WIRE)–The Board of Directors of NewMarket Corporation (NYSE: NEU) declared a quarterly dividend…
Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., April 27, 2023 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…